The current treatments for patients with RA (DMARDs, NSAIDs, and anti-TNF biologics) intend to disrupt the inflammatory response and slow disease progression; however, their chronic consumption may lead to unwanted side effects (immunosuppression and infections) and prevent optimal resolution and tissue repair, which is imperative in RA. Here, TNF is linked to rheumatoid arthritis.